What is Perfinity Biosciences?
Perfinity Biosciences is a specialized entity focused on developing and delivering high-throughput consumable kits and automated instrument solutions. Their core mission is to provide laboratory professionals with tools that yield easy, accurate, and reproducible results. Key product lines include SMART Digest, Soluble SMART Digest, and SMART Digest Immunoaffinity products, complemented by a suite of analytical services such as ADC Biotransformation Monitoring and Peptide Mapping. The company primarily serves the life sciences sector, catering to clients who require sophisticated analytical instrumentation for the characterization of proteins and oligonucleotides. Perfinity's commitment to speed and user-friendliness aims to significantly improve the efficiency of research and development workflows within these organizations.
How much funding has Perfinity Biosciences raised?
Perfinity Biosciences has raised a total of $69K across 1 funding round:
Debt
$69K
Debt (2021): $69K with participation from PPP
Key Investors in Perfinity Biosciences
PPP
Public-Private Partnership
What's next for Perfinity Biosciences?
With the recent substantial expansion capital, Perfinity Biosciences is poised for a significant phase of growth. The company's strategic positioning at the Series B/C stage suggests a focus on scaling operations, enhancing product development, and potentially expanding its market footprint. Future initiatives are likely to involve further innovation in their automated instrument solutions and consumable kits, alongside the expansion of their analytical service offerings. This investment will be critical in solidifying Perfinity's role as a key provider of advanced analytical tools for protein and oligonucleotide characterization, driving efficiency and accuracy in life science research and development.
See full Perfinity Biosciences company page
